NOVEL MECHANISMS OF MITOCHONDRIAL FREE RADIAL GENERATION
线粒体自由基产生的新机制
基本信息
- 批准号:6625924
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-11 至 2004-11-30
- 项目状态:已结题
- 来源:
- 关键词:Krebs' cycle Parkinson's disease alpha ketoglutarate cell death central neural pathway /tract electron transport enzyme activity enzyme mechanism free radical oxygen gene environment interaction genetic susceptibility laboratory rat methylphenyltetrahydropyridine mitochondrial disease /disorder nerve injury neural degeneration neurotoxicology neurotoxins oxidative stress oxoglutarate dehydrogenase substantia nigra superoxides tissue /cell culture
项目摘要
DESCRIPTION (provided by applicant)
Although evidence suggests that mitochondrial dysfunction stimulates the
production of reactive oxygen species (ROS) that trigger dopaminergic cell
death in Parkinson's disease (PD) the molecular mechanisms responsible for
mitochondrial ROS production are unknown. We have recently discovered that the
multi-subunit enzyme alpha-ketoglutarate dehydrogenase (alpha-KGDC) is a
substantial source of ROS production in brain mitochondria. The activity and
immunoreactivity of this protein has been shown to be altered in neurons and in
the brains of animals treated with MPP' and in the substantia nigra of patients
with PD. We hypothesize that dysregulation in the intramolecular electron
transfer within the subunits of alpha-KGDC is a primary mediator of oxidative
stress associated with PD and to ROS-mediated neuronal cell death. The specific
aims of this exploratory project are: 1. Quantify the contribution of
alpha-KGDC to ROS production in isolated brain mitochondria in the absence and
presence of PD-associated neurotoxins. We will compare the ROS production by
alpha-KGDC, other mitochondrial dehydrogenases and electron transport chain
Complex I. We will also determine if the ROS generated by alpha-KGDC and
Complex I interact to decrease normal enzyme activity while increasing
production of ROS. 2. Explore possible chemical mechanisms of ROS production by
different enzyme subunits of the alpha-KGDC. 3. Develop a cell culture model
for assessing the contribution of alpha-KGDC to oxidative stress and the
interactions of alpha-KGDC and Complex I in the absence and presence of
neurotoxins. We will measure the effects of MPP' in the absence and presence of
high extracellular alpha-ketoglutarate and alpha-KGDC inhibitors on markers of
protein and DNA oxidation. The effects of different culture conditions on
alpha-KGDC and Complex I enzyme activities and on H2O2 production will be
measured using mitochondria isolated from these cells. This project will lay
the foundation for the molecular etiology of cell death in PD which could be
activated by genetic and (or) environmental determinants. Verification of the
role of alpha-KGDC in mitochondrial ROS generation and in oxidative cell death
could lead to the development of genetic animal models of susceptibility to PD
disease leading to the development of targeted neuroprotective interventions
that will minimize the incidence or slow the progression of Parkinson's
disease.
描述(由申请人提供)
尽管有证据表明线粒体功能障碍刺激了
产生触发多巴胺能细胞的活性氧(ROS)
帕金森氏病(PD)死亡的分子机制
线粒体ROS的产生尚不清楚。我们最近发现
多生酶α-酮戊二酸脱氢酶(alpha-kGDC)是一个
大脑线粒体中ROS产生的大量来源。活动和
该蛋白的免疫反应性已显示在神经元和
用MPP治疗的动物和患者的黑质的动物大脑
与PD。我们假设分子内电子失调
在α-KGDC亚基内转移是氧化的主要介体
与PD和ROS介导的神经元细胞死亡相关的应力。具体
该探索性项目的目的是:1。量化
在不存在的情况下,α-kGDC在孤立的脑线粒体中产生ROS,并且
PD相关的神经毒素的存在。我们将通过比较ROS的生产
α-KGDC,其他线粒体脱氢酶和电子传输链
复合物I。我们还将确定Alpha-KGDC产生的ROS是否和
复合物I相互作用以减少正常酶活性,同时增加
ROS的生产。 2。通过
α-KGDC的不同酶亚基。 3。开发细胞培养模型
评估α-kGDC对氧化应激的贡献和
在不存在和存在的情况下,α-KGDC和复合物I的相互作用
神经毒素。我们将在不存在和存在的情况下测量MPP的影响
高细胞外α-酮戊二酸和α-kGDC抑制剂在标记上
蛋白质和DNA氧化。不同培养条件对
alpha-kGDC和复杂的I酶活性以及H2O2的生产将是
使用从这些细胞分离的线粒体测量。这个项目将奠定
PD中细胞死亡分子病因的基础,这可能是
被遗传和(或)环境决定因素激活。验证
α-KGDC在线粒体ROS产生和氧化细胞死亡中的作用
可能导致发展PD易感性的遗传动物模型
导致靶向神经保护干预措施的发展
这将使帕金森氏症的发病率最小
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY M FISKUM其他文献
GARY M FISKUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY M FISKUM', 18)}}的其他基金
Optimal Oxygenation and Gene Expression During Critical Care after Cardiac Arrest
心脏骤停后重症监护期间的最佳氧合和基因表达
- 批准号:
9278278 - 财政年份:2015
- 资助金额:
$ 18.56万 - 项目类别:
Optimal Oxygenation and Gene Expression During Critical Care after Cardiac Arrest
心脏骤停后重症监护期间的最佳氧合和基因表达
- 批准号:
9146416 - 财政年份:2015
- 资助金额:
$ 18.56万 - 项目类别:
EXPERIMENTAL SWELLING OF ISOLATED NEURONAL MITOCHONDRIA
离体神经元线粒体的实验肿胀
- 批准号:
6976411 - 财政年份:2004
- 资助金额:
$ 18.56万 - 项目类别:
Mitochondrial Mechanisms of Hypoxic Ischemic Neonatal Brain injury
新生儿缺氧缺血性脑损伤的线粒体机制
- 批准号:
7013469 - 财政年份:2004
- 资助金额:
$ 18.56万 - 项目类别:
NOVEL MECHANISMS OF MITOCHONDRIAL FREE RADIAL GENERATION
线粒体自由基产生的新机制
- 批准号:
6480123 - 财政年份:2002
- 资助金额:
$ 18.56万 - 项目类别:
Novel delivery of Bcl-2 for neuroprotection
用于神经保护的 Bcl-2 新型递送
- 批准号:
6683609 - 财政年份:2002
- 资助金额:
$ 18.56万 - 项目类别:
相似国自然基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
- 批准号:82371251
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
DJ-1与Calnexin互作调控线粒体—内质网联络区参与帕金森病病理机制的研究
- 批准号:82371414
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
帕金森氏病肠道菌群联合多模态磁共振影像的肠菌-肠-脑轴作用机制研究
- 批准号:82101323
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
一种小分子线粒体自噬激活剂用于治疗帕金森氏病的实验研究
- 批准号:82003721
- 批准年份:2020
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
单枚弧形电极植入丘脑底核-桥脚核双核团用于帕金森病治疗中的生物学效应及其拓扑学机制
- 批准号:81901395
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 18.56万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 18.56万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 18.56万 - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)